Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa.
Afr J Reprod Health
; 25(1): 41-48, 2021 Feb.
Article
en En
| MEDLINE
| ID: mdl-34077109
Implanon NXT was introduced in South Africa (SA) in 2014 to expand the contraceptive method mix. While studies have explored patterns of implant use, data on contraceptive choice following implant removal is limited. Here, we describe contraceptive choice among 120 women requesting Implanon NXT removal, between 2017 and 2018, at an urban reproductive health clinic in Durban, SA. Among women who used the implant for three years (n=91), >50% chose to reinsert Implanon NXT. Reasons for choosing to reinsert included satisfaction with the implant, the desire for a long-acting method and having had no side effects. A third of women chose not to reinsert Implanon NXT after three years due to side effects such as problematic bleeding. Most women requesting early removal of the implant switched to male condoms, injectables or oral contraceptives. Contraceptive services should provide women with contraceptive options and allow women to make informed decisions regarding contraceptive choice, in addition to providing support and managing side effects among Implanon NXT users.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Conducta de Elección
/
Desogestrel
/
Anticonceptivos Femeninos
/
Remoción de Dispositivos
/
Prioridad del Paciente
/
Agentes Anticonceptivos Hormonales
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Idioma:
En
Revista:
Afr J Reprod Health
Asunto de la revista:
MEDICINA REPRODUTIVA
Año:
2021
Tipo del documento:
Article